Molecules (Jun 2020)

Imunofan—RDKVYR Peptide—Stimulates Skin Cell Proliferation and Promotes Tissue Repair

  • Justyna Sawicka,
  • Maria Dzierżyńska,
  • Anna Wardowska,
  • Milena Deptuła,
  • Piotr Rogujski,
  • Paweł Sosnowski,
  • Natalia Filipowicz,
  • Alina Mieczkowska,
  • Piotr Sass,
  • Anna Pawlik,
  • Aleksandra Hać,
  • Adriana Schumacher,
  • Magdalena Gucwa,
  • Natalia Karska,
  • Jolanta Kamińska,
  • Rafał Płatek,
  • Jarosław Mazuryk,
  • Jacek Zieliński,
  • Karolina Kondej,
  • Piotr Młynarz,
  • Piotr Mucha,
  • Piotr Skowron,
  • Łukasz Janus,
  • Anna Herman-Antosiewicz,
  • Paweł Sachadyn,
  • Artur Czupryn,
  • Arkadiusz Piotrowski,
  • Michał Pikuła,
  • Sylwia Rodziewicz-Motowidło

DOI
https://doi.org/10.3390/molecules25122884
Journal volume & issue
Vol. 25, no. 12
p. 2884

Abstract

Read online

Regeneration and wound healing are vital to tissue homeostasis and organism survival. One of the biggest challenges of today’s science and medicine is finding methods and factors to stimulate these processes in the human body. Effective solutions to promote regenerative responses will accelerate advances in tissue engineering, regenerative medicine, transplantology, and a number of other clinical specialties. In this study, we assessed the potential efficacy of a synthetic hexapeptide, RDKVYR, for the stimulation of tissue repair and wound healing. The hexapeptide is marketed under the name “Imunofan” (IM) as an immunostimulant. IM displayed stability in aqueous solutions, while in plasma it was rapidly bound by albumins. Structural analyses demonstrated the conformational flexibility of the peptide. Tests in human fibroblast and keratinocyte cell lines showed that IM exerted a statistically significant (p p p < 0.05) in fibroblasts and activation of genes involved in immune responses, migration, and chemotaxis in adipose-derived stem cells derived from surgery donors. Experiments in a model of ear pinna injury in mice indicated that IM moderately promoted tissue repair (8% in BALB/c and 36% in C57BL/6 in comparison to control).

Keywords